Oncoclinicas do Brasil (ONCO3) — Cash Flow-to-Debt Ratio
Oncoclinicas do Brasil (ONCO3) has a Cash Flow-to-Debt Ratio of 0.02x as of September 2025, meaning its operating cash flow of R$151.75 Million could theoretically repay 0% of its total liabilities (R$7.02 Billion) in one year. See free cash flow generation of Oncoclinicas do Brasil to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Oncoclinicas do Brasil Cash Flow-to-Debt Ratio (2013–2024)
Historical debt coverage capacity for Oncoclinicas do Brasil across 12 annual periods. Also explore net asset momentum of Oncoclinicas do Brasil to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Oncoclinicas do Brasil (2013–2024)
Year-by-year debt coverage analysis for Oncoclinicas do Brasil. For market capitalisation and broader financial context, see ONCO3 market cap overview.
| Year | CF-to-Debt Ratio | Operating CF (BRL) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.02x | R$-184.85 Million | R$7.82 Billion | ▼ -198.1% |
| 2023 | -0.01x | R$-51.56 Million | R$6.50 Billion | ▲ +83.7% |
| 2022 | -0.05x | R$-271.64 Million | R$5.59 Billion | ▼ -1852.2% |
| 2021 | 0.00x | R$-9.28 Million | R$3.73 Billion | ▼ -106.9% |
| 2020 | 0.04x | R$97.56 Million | R$2.71 Billion | ▼ -46.1% |
| 2019 | 0.07x | R$97.08 Million | R$1.45 Billion | ▲ +50.9% |
| 2018 | 0.04x | R$38.86 Million | R$878.19 Million | ▼ -81.9% |
| 2017 | 0.24x | R$135.26 Million | R$553.99 Million | ▲ +541.6% |
| 2016 | -0.06x | R$-20.71 Million | R$374.51 Million | ▼ -483.0% |
| 2015 | -0.01x | R$-3.10 Million | R$326.58 Million | ▼ -134.5% |
| 2014 | 0.03x | R$9.29 Million | R$338.17 Million | ▲ +1.8% |
| 2013 | 0.03x | R$7.34 Million | R$272.27 Million | — |